Table 3.
Definitions of variables in chart review for patients diagnosed with NSCLC in our single-institutional cohort.
| Variable | Definition | Timing of Variable | Included in model | Remarks |
|---|---|---|---|---|
| Age at NSCLC diagnosis | The age at which patient was first ever diagnosed with NSCLC | At diagnosis | Baseline & extended | |
| Primary NSCLC tumor size | Measurement in centimeters (cm) of largest diameter of primary NSCLC tumor | At diagnosis | Baseline & extended | |
| Overall stage | Clinical stage of patient’s NSCLC | |||
| T stage | Clinical T stage | At diagnosis | Baseline & extended | |
| N stage | Clinical N stage | At diagnosis | Baseline & extended | |
| M stage | Clinical M stage | At diagnosis | Baseline & extended | |
| Histologic grading | Histologic grade of primary NSCLC tumor | Follow-up data | N/A | Classified as “unknown” when grade was not determined or data was missing |
| Histologic subtype | Classification of the histologic subtype of primary NSCLC | Follow-up data | Extended only | Placed into subgroups of adenocarcinoma, squamous cell carcinoma, large cell carcinoma, or other |
| Surgery | Y/N status of whether patient received surgery for resection of primary NSCLC tumor | Follow-up data | Extended only | |
| Radiation | Y/N status of whether patient received radiation for treatment of primary NSCLC tumor | Follow-up data | Extended only | |
| Chemotherapy | Y/N status of whether patient received chemotherapy for treatment of primary NSCLC tumor | Follow-up data | Extended only | |
| EGFR | Mutational status of EGFR | Follow-up data | N/A | |
| Metastatic Disease | Y/N status of whether patient was ever diagnosed with NSCLC metastatic disease (at time of NSCLC diagnosis or anytime thereafter) | Follow-up data | N/A | |
| Number of extracranial metastatic sites | Number of metastatic sites of disease other than brain | Follow-up data | Extended only | |
| Number of brain metastases | Number of NSCLC brain metastases (diagnosed at time of NSCLC diagnosis or anytime thereafter) | Follow-up data | N/A |